DOCSLIB.ORG

Steven J. Cohen, Md

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Steven J. Cohen, Md STEVEN J. COHEN, MD Background Oncology Cornell University Director, Rosenfeld Cancer Center and Cancer Service Line Ithaca, NY Chief, Medical Oncology and Hematology Division (BA, Psychology, 1988-1992) Vice-Chair, Department of Medical Oncology Professor of Medical Oncology, Thomas Jefferson University, Stony Brook University School of Medicine Sidney Kimmel Cancer Center Stony Brook, NY (MD, 1992-1996) Steven J. Cohen, MD earned his Bachelor’s degree in Psychology Temple University Hospital in 1992 from Cornell Philadelphia, PA University. In 1996, he earned (Resident, Internal Medicine, 1996-1999) his medical degree from the State University of New York at Fox Chase Cancer Center Stony Brook. Dr. Cohen Temple University Hospital completed his residency in Philadelphia, PA Internal Medicine at Temple (Fellow, Medical Oncology and Hematology, 1999-2001) University Hospital in 1999. He (Chief Fellow, Medical Oncology and Hematology, 2001- completed his fellowship in 2002) Medical Oncology and (Program Director, Hematology/Oncology Fellowship, Hematology in 2002 at Fox 2009-2016) Chase Cancer Center, and also served as Chief Fellow from 2001 to 2002. Fox Chase Cancer Center Philadelphia, PA Dr. Cohen specializes in the care and treatment of GI cancers. He is a member of the American Society of Clinical (Assistant Member, Division of Medical Science, 2002- Oncology, where he has served on the Scientific Program 2004) Committee for Colorectal Cancer and chaired the Test (Attending Physician, Department of Medical Oncology, Development Committee. He is an active member of the GI 2002-2004) Committee of the Eastern Cooperative Oncology Group (Assistant Professor, Divisions of Medical and Population where he has chaired the Colorectal Cancer Subcommittee. Science, 2004-2010) Further, he is a board member of the Pennsylvania Society (Associate Professor, Department of Medical Oncology, of Oncology and Hematology. Dr. Cohen also has served as 2010-2016) the vice-chair of the National Cancer Institute’s Pancreatic (Chief, GI Medical Oncology; Co-Leader, GI Cancer Service Cancer Task Force of the GI Steering Committee. Line, 2011-2016) Prior to coming to Abington – Jefferson Health, Dr. Cohen Fox Chase Cancer Center Partners was chief of the GI Medical Oncology program at Fox Chase Philadelphia, PA Cancer Center and program director of the (Associate Medical Director, 2004-2011) hematology/oncology fellowship program. He also had (Chief Medical Officer, 2012-2016) oversight of medical oncology within the Fox Chase Partners, Fox Chase’s affiliate program. Awards NCI Clinical Investigator Team Leadership Award Dr. Cohen has served as the principal or co-investigator of ASCO Leadership Development Program Graduate numerous clinical trials in gastrointestinal cancer. His research interests in gastrointestinal cancer focus on the Contact Information development of new therapies for patients with Dr. Cohen can be reached at: gastrointestinal cancer, including pancreatic cancer and colorectal cancer. He has published original work in nearly Division of Medical Oncology and Hematology 100 peer-reviewed publications and is widely regarded as a Abington Cancer Care Specialists national expert in the treatment of patients with Rosenfeld Cancer Center gastrointestinal cancers. Dr. Cohen has been a guest 1200 Old York Road, 1 Widener lecturer at numerous lectures and symposiums. Abington, PA 19001 Office: 215-481-2400 Fax: 215-481-7438 Department of Medical Oncology Sidney Kimmel Cancer Center at Jefferson 925 Chestnut Street, Suite 320A Philadelphia, PA 19107 Office: 215-955-8874 Fax: 215-955-2340 Jefferson.edu/AbingtonHealthPhysicians .
Load more

Recommended publications
  • Springer A++ Viewer
    PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central Ubiquitin researchers win Nobel ArticleInfo ArticleID : 5007 ArticleDOI : 10.1186/gb-spotlight-20041007-02 ArticleCitationID : spotlight-20041007-02 ArticleSequenceNumber : 70 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 3 RegistrationDate : 2004–10–7 ArticleHistory : OnlineDate : 2004–10–7 ArticleCopyright : BioMed Central Ltd2004 ArticleGrants : ArticleContext : 130595511 Stephen Pincock Email: [email protected] Three researchers who made fundamental breakthroughs in understanding ubiquitin-mediated proteolysis have been awarded the 2004 Nobel Prize in Chemistry, the Royal Swedish Academy of Sciences said on Wednesday (October 6). Aaron Ciechanover and Avram Hershko, from the Israel Institute of Technology, Haifa, and Irwin Rose, of the University of California, Irvine, will share the prize for their discoveries in the 1970s and 1980s that began to reveal the central role of the tiny 76-amino acid protein in numerous cellular processes. "Thanks to the work of the three laureates, it is now possible to understand at a molecular level how the cell controls a number of central processes by breaking down certain proteins and not others," the academy said. "Without doubt they deserve this prize," John Mayer, professor of molecular cell biology at the University of Nottingham, told us. "Protein modification by ubiquitylation is just as important as protein phosphorylation for what goes on in the cell." Ubiquitin-mediated protein degradation governs processes as varied as cell division, DNA repair, quality control of newly produced proteins, and parts of the immune system. Problems with the ubiquitin–proteosome system are implicated in human diseases including cervical cancer and cystic fibrosis. "The reason they've got this Nobel Prize is because ubiquitin is attached to proteins in different ways not only for degradation, but also to make other things happen in the cell," Mayer added.
    [Show full text]
  • Ubiquitin-Mediated Proteolysis the Nobel Prize in Chemistry for 2004 Is
    Advanced information on the Nobel Prize in Chemistry, 6 October 2004 Information Department, P.O. Box 50005, SE-104 05 Stockholm, Sweden Phone: +46 8 673 95 00, Fax: +46 8 15 56 70, E-mail: [email protected], Website: www.kva.se Ubiquitin-mediated proteolysis The Nobel Prize in Chemistry for 2004 is shared between three scientists who have made fundamental discoveries concerning how cells regulate the breakdown of intracellular proteins with extreme specificity as to target, time and space. Aaron Ciechanover, Avram Hershko and Irwin Rose together discovered ubiquitin- mediated proteolysis, a process where an enzyme system tags unwanted proteins with many molecules of the 76-amino acid residue protein ubiquitin. The tagged proteins are then transported to the proteasome, a large multisubunit protease complex, where they are degraded. Numerous cellular processes regulated by ubiquitin-mediated proteolysis include the cell cycle, DNA repair and transcription, protein quality control and the immune response. Defects in this proteolysis have a causal role in many human diseases, including a variety of cancers. Fig. 1 Ubiquitin-mediated proteolysis and its many biological functions 2 Introduction Eukaryotic cells, from yeast to human, contain some 6000 to 30000 protein-encoding genes and at least as many proteins. While much attention and research had been devoted to how proteins are synthesized, the reverse process, i.e. how proteins are degraded, long received little attention. A pioneer in this field was Schoenheimer, who in 1942 published results from isotope tracer techniques indicating that proteins in animals are continuously synthesized and degraded and therefore are in a dynamic state (Schoenheimer, 1942).
    [Show full text]
  • Proteasome Inhibitors in Cancer Therapy: Death by Indigestion
    Cell Death and Differentiation (2005) 12, 1255–1257 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Book Review Proteasome inhibitors in cancer therapy: death by indigestion M Rossi1, A Oberst2, A Emre Sayan1 and P Salomoni*,1 1 MRC, Toxicology Unit, Leicester, UK; 2 IDI-IRCCS Biochemistry Lab, c/o University of Rome Tor Vergata, Rome, Italy * Corresponding author. P Salomoni. E-mail: [email protected] Cell Death and Differentiation (2005) 12, 1255–1257. doi:10.1038/sj.cdd.4401701 Proteasome Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. By J Adams. Humana Press, Totowa, New Jersey: 2004. pp 312. ISBN: 1-58829-250-9 As Eugene Garfield said, while it is easy to recognize a good same issue containing manuscripts from scientists that have paper, it could be more difficult to recognize a bad paper. In originated in this field.7–10 fact, the results could be weak, but the conclusion could still For those of us engaged in basic research in the field be right, even though not fully supported by the data shown. of cancer and apoptosis, the hope that our work might, in Preliminary reports could also fall in this category. After some small way and at some future juncture, contribute to all, it was not a Cell but a BBRC paper – only a little BBRC of the clinical treatment of human cancers is a major motivator. three impact factor – describing a novel experimental model Proteasome Inhibitors in Cancer Therapy, edited by Julian in which to study ATP-dependent proteolysis.1 In a lysate Adams, which is part of the ‘Cancer Drug Discovery and from rabbit reticulocytes, where the proteolytic activity was not Development’ series from Humana Press, tells the happy tale due to lysosomes (pH optimum of 7.8), they separated two of one drug’s journey from concept, through development, fractions in a DEAE cellulose column, each one individually to FDA approval, and application.
    [Show full text]
  • The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell Division Cycle*
    Cell Death and Differentiation (2005) 12, 1191–1197 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Review: Nobel Lecture The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle* A Hershko*,1 further molecular mechanisms that regulate the expression of specific genes. Owing to the intensive research activity on 1 The B. Rappaport Faculty of Medicine and the Rappaport Institute for protein synthesis, little attention was paid at that time to the Research in the Medical Sciences, Technion-Israel Institute of Technology, fact that many proteins are rapidly degraded to amino acids. Haifa, Israel This dynamic turnover of cellular proteins had been previously * Corresponding author: A Hershko, Unit of Biochemistry, the B. Rappaport known by the pioneering work of Schoenheimer and co- Faculty of Medicine and the Rappaport Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, 1 Efron Street, P.O. Box workers, who were among the first to introduce the use of 9649, Haifa 31096, Israel. Fax: 9724 853 5773; isotopically labeled compounds to biological studies. They 15 E-mail: [email protected] administered N-labeled L-leucine to adult rats, and the distribution of the isotope in body tissues and in excreta was Received 18.5.05; accepted 18.5.05 examined. It was observed that less than one-third of the Edited by G Melino isotope was excreted in the urine, and most of it was incorporated into tissue proteins.1 Since the weight of the Abstract animals did not change during the experiment, it could be assumed that the mass and composition of body proteins also Owing to the intensive research activity on protein synthesis, did not change.
    [Show full text]
  • Early Work on the Ubiquitin Proteasome System, an Interview with Irwin Rose
    Cell Death and Differentiation (2005) 12, 1162–1166 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Interview Early work on the ubiquitin proteasome system, an interview with Irwin Rose I Rose*,1 Irwin Rose was one of the first scientists working on UPS mechanisms. In particular, his early work was dedicated to the 1 Department of Physiology and Biophysics, College of Medicine, University of biochemistry and the role of nonlysosomal protein degra- California, Irvine, CA 92697, USA dation. But how did it all begin? What triggered his scientific * Corresponding author: I Rose, Department of Physiology and Biophysics, interest in this field from his previous work? Now a large College of Medicine, University of California, Irvine, CA 92697, USA. family of related proteins exist, with interesting therapeutical E-mail: [email protected] potential. Here, Cell Death and Differentiation asks Irwin Cell Death and Differentiation (2005) 12, 1162–1166. Rose about the early work on enzymology. This interview doi:10.1038/sj.cdd.4401700 was obtained, thanks to the kind help of the Nobel Foundation in Stockholm, http://nobelprize.org (rThe Nobel Founda- tion 2004). CDD: How did you Move from your Early Family Life into your Scientific Interest? We left my birthplace, Brooklyn, New York in 1939 when I was 13. I enjoyed the ethnic variety and the interesting students in my public school, P.S. 134. The kids in my neighborhood were only competitive in games although unfriendly gangs tended to define the limits of our neighborhood. The major extracurricular activities that I can remember were a Victory Garden on school grounds, our contribution to the war effort, and a favorite sport, handball, played between the walls of our apartment house.
    [Show full text]
  • June 06 Obit.Indd
    Cecile M. Pickart 1954–2006 On April 5 2006, Cecile Pickart, an outstanding biochemist, died follow- ing a protracted battle with kidney cancer. She was only fifty-one years old. The biomedical research community has lost a superb scientist, valued colleague and dear friend. A memorial celebrating Cecile’s life and scientific contributions is being planned for July 21 this year at the Bloomberg School of Public Health at Johns Hopkins University. Cecile had been a leading investigator in the ubiquitin field from its infancy and she continued to make some of the most seminal discover- ies in the field until her death — a point where the field had matured into an enterprise involving thousands of researchers around the world. Photo courtesy of the Bloomberg School of Public Health, John Hopkins University After graduating summa cum laude in 1976 with a B.S. degree in biology from Furman University in Greenville, South Carolina, Cecile earned These polyubiquitin chains were used for the first structural studies of a Ph.D. in biochemistry from Brandeis University. There, she cut her ubiquitin polymers, allowing Cecile and her colleagues to identify key teeth in enzymology under the tutelage of one of the premier enzymolo- residues on the ubiquitin surface that participate in proteasome binding gists of the day, William Jencks. In 1982, she left to study with another and other ubiquitin functions. She then worked out a method to attach renowned enzymologist, Irwin Rose, at the Fox Chase Cancer Center in these chains to substrate proteins. This beautiful work culminated in a Philadelphia, where she began her studies on ubiquitin.
    [Show full text]
  • Fox Chase Cancer Center Oncology Nurse Core Curriculum Review Program
    Fox Chase Cancer Center Oncology Nurse Core Curriculum Review Program Tuesday, September 18, 2018 (7:15 AM - 4:15 PM) Thursday, September 20, 2018 (7:15 AM - 4:15 PM) Tuesday, September 25, 2018 (7:15 AM - 3:00 PM) Fox Chase Cancer Center Center Building Auditorium 333 Cottman Avenue Philadelphia, PA 19111 The Oncology Nurse Core Curriculum Review Program will provide registered nurses with the knowledge necessary to begin their preparation for the national certification provided by the Oncology Nursing Certification Corporation. Oncology Nurse Core Curriculum Tuesday, September 18, 2018 7:15am Registration 7:30am - 7:45am Greeting and Announcements Bernadette Ciukurescu, BSN, RN-BC 7:45am - 8:45am Health Promotion, Prevention, & Genetics Susan Montgomery, BSN, RN, OCN, GCN 8:45am - 9:45am Cancer Pathophysiology Margaret Bernesky, MSN, RN, OCN 9:45am - 10:00am BREAK 10:00am - 11:30am Breast Cancer & Reproductive Cancers Kathy Smith, CRNP 11:30am - 12:30pm Cancers ofWednesday the GI System Marie JanuaryRiehl, BSN, RN, 17,OCN and 2018 Sandra Wetherbee, MSN, RN, OCN 12:30pm - 1:15pm LUNCH 7:15 a.m.-4:15 p.m. 1:15pm - 2:45pm Lung Cancer & Head and Neck Cancer Kristen Kreamer, CRNP MSN AOCNP APN-BC 2:45pm – 4:15pm Cancers of the Genitourinary System Susan Roethke, MSN, ANP-BC, AOCNP CRNP Thursday, September 20, 2018Wednesday January 24, 2018 7:15am Registration 7:30 a.m.—4:30 p.m. 7:30am - 7:35am Greeting and Announcements Bernadette Ciukurescu, BSN, RN-BC 7:35am - 8:35am Survivorship & Palliative and End of Life Care Kate Murphy, CRNP 8:35am
    [Show full text]
  • New Patient Guide 2018-FNL 0.Pdf
    WELCOME TO FOX CHASE CANCER CENTER GUIDE FOR NEW PATIENTS TABLE OF CONTENTS Welcome ......................................................................................................................................................1 Designations and Awards ........................................................................................................................2 Getting Here ................................................................................................................................................3 Hotels and Lodging ...................................................................................................................................5 Your First Visit ............................................................................................................................................6 Language Interpreter Service .................................................................................................................8 Your Care Team ..........................................................................................................................................9 After Your Visit ........................................................................................................................................ 10 Contacting Your Care Team ................................................................................................................... 10 Scheduling ..............................................................................................................................................
    [Show full text]
  • The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell Division Cycle
    K6_40319_Hershko_176-200 05-09-02 15.24 Sida 187 THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION AND SOME OF ITS ROLES IN THE CONTROL OF THE CELL DIVISION CYCLE Nobel Lecture, December 8, 2004 by Avram Hershko Unit of Biochemistry, the Rappaport Faculty of Medicine and Research Institute, Technion – Israel Institute for Technology, Haifa, Israel. INTRODUCTION All living cells contain many thousands of different proteins, each of which carries out a specific chemical or physical process. Due to the importance of proteins in basic cellular functions, there has been a great interest in the problem of how proteins are synthesized. In the fifties and sixties of the 20th century, the discovery of the double helical structure of DNA and the cracking of the genetic code focused attention on the mechanisms by which the order of bases in DNA determines the sequence of amino acids in proteins, and on further molecular mechanisms that regulate the expression of specific genes. Because of the intensive research activity on protein synthesis, little attention was paid to at that time to the fact that many proteins are rapidly degraded to amino acids. This dynamic turnover of cellular proteins had been previously known by the pioneering work of Schoenheimer and co-workers, who were among the first to introduce the use of isotopically labeled compounds to biological studies. They administered 15N-labeled L-leucine to adult rats, and the distribution of the isotope in body tissues and in excreta was examined. It was observed that less than one-third of the isotope was excreted in the urine, and most of it was incorporated into tissue proteins (1).
    [Show full text]
  • Community Resources Temple University
    WINTER 2017 A GUIDE TO Community Resources OFFERED AT Temple University TEMPLE COMMUNITY SCHOLARSHIPS Each year, Temple University awards up to 25 scholarships to ambitious, college-bound students from ZIP codes 19121, 19122, 19132 and 19133 in North Philadelphia. For more information about Temple’s 20/20 scholarships, visit sfs.temple.edu. TABLE OF CONTENTS COMMUNITY CONNECTIONS HEALTHCARE Welcome ...........................................2 Location Information................... 13 Community Relations ...................3 Medical Care Family Practice ......................... 13 ARTS AND CULTURE Women and Infants .................. 14 Oral Health ..................................... 14 Foot Care ........................................ 15 Temple Libraries .............................4 Specialty Health Services Community Arts .............................4 Heart Health ............................... 15 Performing Arts ..............................5 Additional Services .................. 16 ATHLETICS SAFETY AND SECURITY Athletics ............................................6 Important Numbers ......................17 CAREER SENIOR CITIZEN SUPPORT Job Training .....................................7 Senior Support Programs .......... 18 Hiring and Employment ...............7 Small Business Development ....8 SUMMER PROGRAMS EDUCATION Featured Summer Programs .... 19 Middle and High School STEM ..............................................9 QUICK REFERENCE After School .................................9 Student Financial Services ..
    [Show full text]
  • Download a Printable Patient Guide
    WELCOME TO FOX CHASE CANCER CENTER GUIDE FOR NEW PATIENTS TABLE OF CONTENTS Welcome ......................................................................................................................................................1 Designations and Awards ........................................................................................................................2 Getting Here ................................................................................................................................................3 Hotels and Lodging ...................................................................................................................................5 Your First Visit ............................................................................................................................................6 Language Interpreter Service .................................................................................................................8 Your Care Team ..........................................................................................................................................9 After Your Visit ........................................................................................................................................ 10 Contacting Your Care Team ................................................................................................................... 10 Scheduling ..............................................................................................................................................
    [Show full text]
  • Fox Chase Cancer Center Geriatric Oncology Program
    Target Audience Location of Event: Fox Chase Cancer Center This program is designed for novice and Center Building Auditorium experienced nurses, Certified Nursing Assistants, 333 Cottman Avenue Clinic Assistants and any other clinicians who are Philadelphia, PA 19111 Fox Chase Cancer Center interested in or working with the geriatric oncology Parking is FREE at Fox Chase Cancer Center! Geriatric Oncology Program population. Please park in the East garage. Course Fee: Registration - $150.00 Continuing Education Credits Fox Chase Partners - $135.00 Fox Chase Cancer Center is an approved provider of TUHS employees - Free continuing nursing education by the Pennsylvania The program includes continental breakfast and lunch State Nurses Association, an accredited approver Registration: by the American Nurses Credentialing Center’s Please register and pay electronically at: Commission on Accreditation. www.foxchase.org/CNE This program is approved for 7.0 contact hours. Cancellations: Awarding of the contact hours is provided for Refunds will be granted up to one week prior to the attendance at the entire conference and completion conference. No refunds will be granted beyond that Wednesday November 15, 2017 of a validation form and evaluation. time period. Schedule is subject to change. 7:30 a.m.—4:30 p.m. Email Policy: Fox Chase Cancer Center respects your right to privacy and will not sell, lease or provide your 7.0 Contact Hours Awarded Completion Criteria contact information to a third party. Participants who attend the entire program and complete the evaluation tool will be awarded 7.0 Wireless Access: Wireless Internet service is available. There is Continuing Education credits.
    [Show full text]